Call us today: 0161 9600 700

Step 3: View your Treatment Package


Vilnius, Lithuania

Meliva Kardiolita Hospital Vilnius

Cost: £5,714 (€6,471)

Please review your Treatment Package below, which includes details about your selected treatment, hospital, and required diagnostic tests.

Your hospital will need specific scans and blood tests to remotely determine your diagnosis before confirming your treatment. You will need to arrange and pay for the diagnostic tests. The cost of the remote examination is included in your Treatment Package price.

Please review your Treatment Package

Your hospital will need specific scans and blood tests to remotely determine your diagnosis

Treatment Package Details

The following is included:

Treatment name:
Coronary Angioplasty
Treatment type:
Cardiac_surgery
Cost:
£5,714 (€6,471)
Head of specialty:
Dr. Justinas Burkauskas
Head of Specialty
Experience:
Dr. Justinas Burkauskas is one of the recognized and experienced Cardiac Specialists of Lithuania. He has extensive experience in his field and conducted various successful procedures and surgeries in his career. He is currently at Meliva Kardiolita Hospital Lithuania as one of the leading Cardiologists and Cardiac Surgeons performing complicated surgeries with a high success rate.
Nights in hospital:
1
Post operative care days:
Not specified

Diagnostics:

Here are the bloods and scans that your hospital requires to confirm your medical diagnosis:

It is always recommended that you ensure you are properly protected for your trip. Traditional travel insurance policies are likely to exclude any travel overseas for medical or dental procedures; we strongly recommend that you do not travel overseas for treatment without appropriate medical travel insurance without insurance protection.

To assist the users of our platform, we have negotiated a discounted policy for the users of our Services with Sure Insurance Services whose Medical Travel Shield policy is designed to protect individuals whilst traveling for treatment abroad.

If you wish to take advantage of this discount, simply type the code MMG10 into the discount box on the Medical Travel Shield website for your premium discount to be automatically applied.

We have negotiated this discount solely to assist you in your Treatment process. MMG does not receive any commission or incentive for this introduction to Sure Insurance Services and we are not authorised by the FCA for the arranging of regulated contracts of insurance.

Hospital Details:

Hospital name:
Meliva Kardiolita Hospital Vilnius
Hospital city:
Vilnius
Hospital country:
Lithuania
Nearest international airport:
Vilnius airport
Hospital director:
Andrius Kostagriz
Total number of beds:
36
Total medical staff:
500
Total annual treatments:
2871
Hospital overview:
Meliva Kardiolita Hospital, located in the Lithuanian capital of Vilnius, is one of the leading private hospitals in the Baltic region and a trusted partner for My Medical Gateway patients seeking high-quality care in Europe. The hospital is accredited by the Joint Commission International (JCI), the globally recognised gold standard for patient safety, clinical governance and hospital management. This accreditation confirms that every procedure and policy at Kardiolita follows the same evidence-based standards required of major UK and Western European institutions.
Scale, Facilities and Management:
Kardiolita operates within the Meliva Healthcare Group (formerly InMedica Group and Kardiolita Clinics), a national network that unites hospital and outpatient services under common clinical protocols and standards. Across Lithuania, Meliva employs over 600 staff and 500 doctors in 45 medical specialties and provides treatment for approximately 298,000 patients each year. The Vilnius hospital is a medium-sized, multi-specialty centre with around 50 inpatient beds, a 10-bed intensive care unit and four fully equipped operating theatres capable of handling high-complexity cardiac, orthopaedic, and general surgical cases. The hospital is directed by Andrius Kostogriz, responsible for overall governance and international partnerships. Under his leadership, Kardiolita has expanded its clinical research links with European institutions and maintained continuous JCI compliance since its original accreditation.
Medical Leadership and Key Specialists:
Kardiolita’s medical team combines senior Lithuanian consultants with international training. Among its most experienced specialists are: Prof. Giedrius Uždavinys, senior cardiac surgeon, who has performed thousands of coronary and valve procedures over five decades of practice; Prof. Audrius Aidietis, interventional cardiologist and electrophysiology specialist; Dr. Antanas Mickevičius MD PhD, Consultant bariatric and upper-gastrointestinal surgeon, who also practises in the UK NHS at the Royal Stoke University Hospital and performs roughly 200 bariatric procedures per year; Dr. Justinas Vaičiulis, orthopaedic and trauma surgeon specialising in minimally invasive shoulder, knee and hip reconstruction; Dr. Vaidotas Zabulis and Dr. Arūnas Grinkevičius, vascular surgeons recognised for expertise in endovenous laser therapy and arterial bypass techniques.
Clinical Services and Technology:
Kardiolita provides an integrated model of diagnosis, surgery and rehabilitation across cardiology, cardiac surgery, orthopaedics, bariatric surgery, general surgery, plastic and reconstructive surgery, urology and gynaecology. Its diagnostic facilities include digital MRI and CT imaging, angiography suites and minimally invasive endoscopic systems. Surgical theatres are equipped for laparoscopic, arthroscopic and endovascular procedures, reducing recovery time and the need for prolonged hospitalisation. A rehabilitation centre within the Meliva network provides physiotherapy, wound care and post-operative cardiac and musculoskeletal rehabilitation, enabling patients to complete recovery in a coordinated setting before returning home.
Performance and Outcomes:
Publicly available clinical data and independent international directories indicate strong performance across major disciplines: Cardiac surgery: success rates exceeding 95 %, with coronary artery bypass grafting survival reported at 99 % for standard-risk patients. Orthopaedics: average post-operative complication rate ≈ 3 %, with prosthetic joint lifespan of 17–18 years. Bariatric surgery: complication rate 3–5 %, achieving 40–100 % excess-weight reduction within two years, depending on the procedure. These statistics originate from audited hospital reporting and verified healthcare directories and demonstrate consistent performance levels comparable with Western European benchmarks.
Patient Safety and Quality Assurance:
Kardiolita’s infection-control programme meets JCI Category I infection-prevention standards, with continuous surveillance and antibiotic stewardship. All intensive-care patients are monitored by consultant anaesthetists 24 hours a day. Surgical pathways follow European Society of Anaesthesiology guidelines for thromboembolism prophylaxis and peri-operative antibiotic timing.
Coordination with MMG:
For patients introduced to Kardiolita by MMG, all arrangements — from initial online consultation to admission, treatment and post-operative follow-up — are managed by an English-speaking international coordination team that are fluent in English. Pre-treatment assessments, laboratory tests and imaging can be organised within 48 hours of arrival, with most patients requiring hospital stays of two to five days, depending on procedure complexity.
Rehabilitation and Continuing Care:
Rehabilitation begins immediately after surgery, guided by physiotherapists and specialist nurses. Cardiac patients enter structured exercise and monitoring programmes, while orthopaedic and bariatric patients receive detailed physiotherapy schedules and nutritional support. The Meliva network also provides tele-consultations and imaging reviews for patients once they return home, maintaining continuity of care.